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Abstract 14 
 15 
Metabolism of protein by gut bacteria is potentially detrimental due to production of toxic 16 
metabolites, such as ammonia, amines, p-cresol, and indole. Consumption of prebiotic 17 
carbohydrates produces specific changes in the composition and/or activity of the microbiota 18 
that may confer benefits upon host wellbeing and health. Here, we have studied the impact of 19 
prebiotics on proteolysis within the gut in vitro.  20 
Anaerobic stirred batch cultures were inoculated with omnivore (n=3) and vegetarian (n=3) 21 
faeces. Four protein sources (casein, meat, mycoprotein and soy protein) with and without 22 
supplementation by a oligofructose enriched-inulin. Bacterial counts, and concentrations of 23 
short chain fatty acids (SCFA), ammonia, phenol, indole, and p-cresol were monitored during 24 
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fermentation. Addition of the fructan prebiotic Synergy1 increased levels of bifidobacteria 25 
(p= 0.000019 and 0.000013 for omnivores and vegetarians respectively). Branched chain 26 
fatty acids (BCFA) were significantly lower in fermenters with vegetarians’ faeces (p=0.004), 27 
reduced further by prebiotic treatment. Ammonia production was lower with Synergy1. 28 
Bacterial adaptation to different dietary protein sources was observed through different 29 
patterns of ammonia production between vegetarians and omnivores. In volunteer samples 30 
with high baseline levels of phenol, indole, p-cresol and skatole, Synergy1 fermentation led 31 
to a reduction of these compounds.  32 
 33 
Importance: Dietary protein intake is high in Western populations which could result in 34 
potentially harmful metabolites in the gut from proteolysis. In an in vitro fermentation model, 35 
addition of prebiotics reduced the negative consequences of high protein levels. 36 
Supplementation with a prebiotic resulted in a reduction of proteolytic metabolites in the 37 
model. A difference was seen in protein fermentation between omnivore and vegetarian gut 38 
microbiotas: bacteria from vegetarian donors grew more on soy and QuornTM, than on meat 39 
and casein with reduced ammonia production. Bacteria from vegetarian donors produced less 40 
BCFA.  41 
Introduction 42 
 43 
Dietary protein levels in western European populations can be as high as 105g/d according to 44 
the Food and Agriculture Organization (1). However, the recommended dietary allowance 45 
(RDA) is 56g/d for men and 46g/d for women (2). This may result in high residual colonic 46 
nitrogen, with dietary protein having escaped digestion in the upper intestine entering the 47 
large gut where it can become a substrate for the colonic microbiota. Approximately 16g of 48 
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protein will be present in the colon following ingestion of 105g protein/day of which 8g are 49 
endogenous and 8g are exogenous (3, 4). Among the endogenous proteins, there are 69.2% 50 
bacterial proteins, 16.9% mucin, 7.65% enzymes, and 6.2% mucosal cells (5, 6).  51 
 52 
Anaerobic metabolism of carbohydrate by gut bacteria produces short chain fatty acids 53 
(SCFA), and gases from different pathways. Production of SCFA, mainly acetate, propionate, 54 
and butyrate, in the lumen is generally believed to mediate health benefits such as 55 
maintaining colonic epithelial cell function, regulate energy intake and satiety, controlling 56 
inflammation, and defend pathogen invasion (7). Microbial breakdown of protein not only 57 
generates SCFA and gases, however, but also ammonia, amines, indolic and phenolic 58 
compounds, and branched chain fatty acids (BCFA) through the deamination and 59 
decarboxylation of amino acids (8). Though evidence on humans is scarce, in studies in rats 60 
and in ex vivo studies, ammonia at a physiologically relevant dose can harm colon barrier 61 
function, shorten colonocyte lifespan, and is co-carcinogenic in rats (9-11). Hydrogen 62 
sulphide can be produced from sulphur containing amino acids and is toxic to colonocytes, 63 
damaging DNA and blocking utilisation of butyrate as an energy source (12-15). Metabolism 64 
of tyrosine, phenylalanine and tryptophan produces phenol, indole, p-cresol and skatole 65 
which are potential carcinogens; phenol and p-cresol can reduce intestinal epithelial barrier 66 
function in vitro (10, 16, 17). BCFAs are generated from branched chain amino acids such as 67 
valine, leucine, and iso-leucine which make them biomarkers for bacterial proteolysis, 68 
however there are no human physiological roles for BCFAs known (18).  69 
 70 
Thus, foods entering the colon can have a health impact on the host, possibly by changing gut 71 
microbiota composition and activity. The International Agency for Research on Cancer (19), 72 
an agency under the World Health Organization (WHO) published a press release in October 73 
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2015: where it classified red meat as “probably carcinogenic to humans”, and processed meat 74 
as “carcinogenic to humans”, with concerns over colorectal cancer (19). Some 75 
epidemiological studies found reduced risk of colorectal cancer (CRC) with high 76 
consumption of dietary fibre, while red meat and processed meat had a positive correlation 77 
with CRC (20-23). Animal protein intake was associated with increased inflammatory bowel 78 
disease (IBD) risk in two Japanese and French studies (24, 25).  79 
 80 
Increased consumption of prebiotics, which can reach the colon resulting in specific changes 81 
in the composition and/or activity in the gastrointestinal microflora, may counter the negative 82 
effects of gut microbial proteolysis in persons ingesting high protein diets (26). Inulin-type 83 
fructans can resist hydrolytic enzymes in the human GI tract and are resistant to small 84 
intestinal absorption, subsequently they become a substrate source for the microbiota within 85 
the large intestine. The impact of inulin on the gut microbiome has been studied using in vitro 86 
and in vivo approaches (27-29). The aim of this study was to understand metabolism of gut 87 
bacteria proteolysis in the distal colon and how prebiotics can affect the proteolysis, 88 
therefore, to investigate the potential of consuming prebiotics to counteract the negative 89 
effect of having high protein diet.  90 
Results 91 
Bacterial Enumeration 92 
 93 
Total bacteria and most microbial groups that were monitored in this study reached the 94 
highest number after 24 hours incubation. However lactobacilli, Faecalibacterium prausnitzii 95 
and Roseburia numbers only increased in the first 10 hours with lactobacilli numbers in 96 
particular declining after 10 hours. Bacterial populations from omnivores and vegetarians 97 
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responded differently to the proteins: faecal bacteria from omnivores had insignificant higher 98 
counts on meat and casein than on soy protein and QuornTM extract, while faecal bacteria 99 
from vegetarians had higher counts on soy protein and QuornTM extract (8.75±0.40 log10 100 
CFU/ml) than meat and casein (8.38±0.47 log10 CFU/ml) (p=0.03).  101 
The vegetarian microbiota had higher bifidobacteria and lactobacilli counts at the beginning 102 
compared to omnivore microbiota (Supplementary Tables 1 and 2).  103 
 104 
In order to investigate proteolytic bacteria, independent t tests were performed to compare 105 
samples with protein addition (casein, meat, mycoprotein and soy protein) and controls at 24 106 
and 48 hours (Figure 1 and 2). Though there are studies confirming that many Bacteroides. 107 
spp., are proteolytic (30), we found no significant changes in Bacteroides. spp. on protein 108 
substrates. Clostridium coccoides, Eubacterium rectale and Clostridium cluster XIVa and 109 
XIVb grew on protein substrates: bacteria from omnivore donors had higher counts 110 
comparing to the control group (p=0.055) while those from vegetarian donors were 111 
significantly higher (p<0.01). Roseburia number did not change with protein added. 112 
Atopobium cluster from both omnivore and vegetarian donors grew on protein substrates with 113 
statistical significance. Clostridial cluster IX populations in cultures inoculated with samples 114 
from vegetarian donors increased on the protein substrates significantly, while cultures with 115 
omnivore samples were not statistically different. Lower counts of clostridial cluster IX in 116 
vegetarian donors’ controls could explain the difference. Desulfovibrio counts were 117 
significantly higher with protein from both omnivore and vegetarian donors. Clostridium 118 
clusters I and II also grew more on proteins however, growth only reached statistical 119 
significance with inocula from vegetarians.  120 
 121 
To investigate how prebiotics may modify the microbiota, independent t tests were used to 122 
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compare cultures with prebiotics and without, after 24 and 48 hours fermentation (Figure 1 123 
and 2). Synergy1 addition significantly boosted the growth of total bacteria, bacteroides, 124 
clostridial cluster IX, bifidobacteria, and lactobacilli with both omnivore and vegetarian 125 
inocula, with bifidobacteria displaying the highest growth on Synergy1. In cultures with 126 
vegetarian donor’ samples, Clostridium coccoides, Eubacterium rectale and Clostridium 127 
cluster XIVa and XIVb, Roseburia, Faecalibacterium prausnitzii, and Atopobium also had 128 
significant higher count with prebiotics than without. There were no inhibitory effects of 129 
prebiotics found on any of bacterial groups monitored in this study. 130 
Organic Acids 131 
 132 
Most organic acids accumulated during fermentation and reached their highest concentrations 133 
at 24 or 48 hours fermentation, with the exception of lactate which transiently increased 134 
during the first 10 hours then gradually decreased to below 1mM at 48 hours. Branched 135 
amino acids such as leucine and isoleucine can be metabolised by faecal bacteria to produce 136 
BCFA indicating proteolytic fermentation. Omnivores had higher BCFA production 137 
(4.03±5.25mM) while vegetarians had little production (1.61±1.60mM) (p=0.004). For 138 
instance, while growing on casein, bacteria from omnivores produced 10.19±8.62 and 139 
13.13±10.93 mM of isobutyrate and isovalerate respectively, while bacteria from vegetarians 140 
produced 2.03±2.16 and 3.52±3.29 mM of isobutyrate and isovalerate (Supplementary Table 141 
1 and 2).  142 
Comparing samples with protein and without at 24 and 48 hours, cultures inoculated with 143 
both omnivore and vegetarian donors had significantly higher concentrations of acetate, 144 
propionate, isobutyrate, butyrate, and isovalerate on protein (Figure 3 and 4). However, 145 
fermentation samples with prebiotics had significantly elevated concentration of acetate and 146 
succinate at 24 and 48 hours, and significantly more lactate at 6 and 10 hours (Figure 3 and 147 
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5). 148 
 149 
Butyric acid production was low in this study and no changes were found in cultures with 150 
omnivores samples; this correlates with the lack of differences in populations of butyrate-151 
producing bacteria (Roseburia and Faecalibacterium prausnitzii). In samples with vegetarian 152 
donors’ inocula, butyrate producers (Clostridium coccoides, Eubacterium rectale and 153 
Clostridium cluster XIVa and XIVb, Roseburia, Faecalibacterium prausnitzii) had 154 
significantly higher counts, however, butyrate production was not significantly increased.  155 
Concentrations of BCFA were lower on prebiotics although without statistical significance. 156 
Variation in BCFA production between donors was seen in this study, therefore, two-way 157 
ANOVA on isovalerate and isobutyrate was used to examine the effect of both treatment and 158 
donor on production. A significant influence of donor on isobutyrate and isovalerate was 159 
found with six donors (p<0.01). Donor variation may indicate that a larger sample size is 160 
needed to observe the inhibitory effect of prebiotics on BCFA production. (Supplementary 161 
Table 3)  162 
Volatile Organic Compounds 163 
 164 
This study quantified four potentially detrimental volatile organic compounds (VOCs) which 165 
were indole, phenol, p-cresol and skatole. Production of these compounds varied with 166 
individual donor and the effect of prebiotics on VOCs production also varied according to 167 
donor diet. Production of VOCs, from highest to lowest, was indole, phenol, p-cresol and 168 
skatole in most cases. However, with soy protein, phenol production was higher than indole 169 
production. With all donors, comparing negative and positive controls, the production of 170 
volatile compounds was reduced by Synergy1. However, comparing cultures on 171 
protein+Synergy1 with cultures on the corresponding protein, production of indole, phenol, 172 
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p-cresol and skatole were inhibited by Synergy1 after 48 hours fermentation with inocula 173 
from omnivore donor 1, omnivore donor 2 and vegetarian donor 1. These three donors 174 
produced relatively high levels of phenol and indole on protein(292.20±521.76 µg/ml) 175 
compared with others (28.92±23.61 µg/ml) (p=0.02). Fermentation models inoculated with 176 
these high VOCs producers, Synergy1+protein models produced significantly less phenol and 177 
indole (113.21±227.94 µg/ml) (p=0.046).  178 
Protein source affected production of VOCs. According to this study, casein resulted in the 179 
highest concentration of VOCs in five donors, this was probably because casein is high in 180 
aromatic amino acids which are the main substrates for bacteria to produce phenolic and 181 
indolic compounds. Omnivore donor 3 had low phenolic production from casein correlating 182 
with this donor’s low total bacterial count (Supplementary Table 4). 183 
Ammonia  184 
 185 
Ammonia is a major metabolite of protein fermentation by faecal bacteria. Ammonia 186 
concentrations increased gradually during fermentation on all substrates together with the 187 
negative control when compared to the positive control. Ammonia concentrations on 188 
Synergy1, however, remained at low levels (17.55±4.53mM at 48 hours for omnivores and 189 
25.47±4.55mM for vegetarians) compared to all protein treatments in this study. The 190 
volunteer diet also influenced the selective fermentation of faecal substrates. With faecal 191 
samples from omnivores, fermentation resulted in higher ammonia levels on casein and meat 192 
extract, however, with faecal samples from vegetarians, soy protein and Quorn extract 193 
produced more ammonia (Figure 6). 194 
 195 
Fermentation on protein for 24 hours resulted in significantly higher concentrations of 196 
ammonia compared to fermentation without protein using both omnivore and vegetarian 197 
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samples (p<0.001). Fermentation on prebiotics resulted in significantly lower concentrations 198 
of ammonia in cultures with omnivore donors’ faecal bacteria (Table 1).  199 
Discussion 200 
Lactate production peaked at 10hours fermentation while other organic acids concentrations 201 
kept increasing. This coincided with counts of lactobacilli and was to be expected as lactate 202 
can be utilised by several bacteria to produce other SCFAs. Changes in propionic acid 203 
producing Bacteroides and Clostridium cluster IX populations were seen and propionic acid 204 
increased in vessels containing Synergy1 with the difference reaching significance with 205 
omnivore donors’ samples (p=0.006). Succinate is an intermediate product for propionate 206 
production, the succinate pathway being widely present in bacteroides (31). The significantly 207 
higher levels of succinate in samples with Synergy1 could be associated with propionate 208 
production by bacteroides. 209 
 210 
Faecal bacteria responded differently on various substrates in pH controlled stirred batch 211 
cultures. Total bacteria number from vegetarians were significantly more on soy protein and 212 
QuornTM than meat and casein. Host dietary habits may explain a preference for different 213 
protein sources. Growth of proteolytic bacteria from the human gut supported this: 214 
Clostridium coccoides and Eubacterium rectale from omnivore microbiota and vegetarian 215 
microbiota grew on meat/casein and soy/QuornTM respectively (Supplementary Tables 1 and 216 
2). Ammonia concentrations also indicate that an omnivore microbiota and a vegetarian 217 
microbiota favour different protein sources based on their host diet. A possible reason is 218 
differences in amino acid composition among various proteins: bacteria that have adapted to 219 
the host diet can breakdown peptides, metabolise amino acids or utilise coupled Stickland 220 
amino acid fermentation.  221 
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By observing fermentation characteristics of the negative controls: saccharolytic 222 
bifidobacterial growth at 6 hours with omnivore faeces occurred, indicating that there was a 223 
small amount of undigested saccharides within the omnivore faecal sample. However, this 224 
was not seen from the vegetarian donors.  225 
Even when total bacteria tend to be more saccharolytic, there were some proteolytic bacteria 226 
present in the gut microbiota. The genus Clostridium contains more than 100 species and 227 
these bacteria can be saccharolytic, proteolytic, or both. Within clostridial clusters I and II, 228 
there are saccharolytic species such as C. butyricum and C. beijerinckii; C. sporogenes and C. 229 
acetobutylicum are both saccharolytic and proteolytic; there are proteolytic species such as C. 230 
limosum and C. histolyticum (32). This might explain why Clostridium spp. grew on 231 
prebiotics with a vegetarian microbiota: saccharolytic types from this genus were likely to be 232 
stimulated by prebiotics. This would also imply that these faecal bacteria from vegetarians 233 
are more saccharolytic than clostridia from omnivore donors.  234 
 235 
Vegetarian donor 1 had the highest production of phenolic and indolic compounds together 236 
with the highest E. coli population which correlate with the ability of E. coli to produce 237 
phenolic compounds (33). Indole and p-cresol are conjugated as indoxyl sulphate and p-238 
cresol sulphate in the human body; before they are excreted via urine, they are toxic to human 239 
endothelial cells, can reflect the progression of chronic kidney diseases, and increase 240 
cardiovascular disease risk for such patients (34-37).  Therefore, reduced production of indole 241 
and p-cresol can benefit human health in many ways.  242 
 243 
Studies feeding rats with different protein sources did not find higher colonic toxicity of 244 
casein comparing with soybean, which is contrary to the phenol and p-cresol results in this 245 
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study (38, 39). Feeding red meat gave higher DNA damage than feeding casein in rats (40). 246 
Similar effects were found in human epidemiological research: dairy products were inversely 247 
correlated with colorectal cancer in Finnish men and New York University women; they 248 
speculated that this protective effect may result from other nutrients in the dairy products but 249 
not from macronutrients such as protein (41, 42). Mycoprotein is a relatively new protein 250 
source from the filamentous fungus Fusarium venenatumsource under the trade mark of 251 
QuornTM  (43). QuornTM products contain all the essential amino acids, are low in fat and high 252 
in dietary fibre. However, in terms of protein fermentation by gut microbiota, QuornTM was 253 
no different to other proteins.  254 
The use of pH controlled stirred batch culture systems allowed rapid analysis of different 255 
protein fermentations by gut microbiota and the impact of prebiotics. This fermentation 256 
system is limited however: SCFAs would be absorbed from the human colon and the digesta 257 
supply would be continuous. 258 
 259 
Some animal studies and human studies have revealed an inhibitory effect of proteolysis by 260 
prebiotics such as resistant starch, FOS, and XOS (44-49). These were investigated by 261 
analysing indolic/phenolic compounds, or nitrogen secretion in the urine and faeces. One of 262 
these studies also compared DNA damage with and without resistant starch in rat colonic 263 
cells, and found that the starch protected cells from DNA damage (46). One possible 264 
mechanism of decreased proteolytic fermentation in the presence of prebiotics is through the 265 
enhanced growth of saccharolytic bacteria requiring more amino acids for growth, reducing 266 
amino acid availability for proteolytic bacteria.  267 
 268 
Differences between the gut microbiotas from vegetarian and omnivore donors are not clear 269 
with three donors, however, fermentation patterns on different substrates were seen in this 270 
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study such as the differences in BCFA, ammonia, and total bacteria. In terms of protein 271 
fermentation by faecal bacteria, based on the different ammonia production and bacteria 272 
growth response to different protein source: microbiota from vegetarian donors have adapted 273 
to vegetarian protein sources and can utilise these proteins more efficiently. In addition, in 274 
this study, lower BCFA production was found with vegetarians’ gut bacteria; this could 275 
suggest that these donors had lower branched chain amino acids in their diet. Prebiotic 276 
supplementation lowered proteolytic metabolites more in cultures with omnivores’ samples 277 
comparing to cultures with vegetarians’ bacteria: vegetarian donors are more likely to be on a 278 
high fibre diet and may need a higher dose of Synergy1 to see a prebiotic effect (50).  279 
 280 
Addition of Synergy1 at the beginning to 48 hour batch culture fermentation changed the 281 
microbiota to a more saccharolytic nature by stimulation of bifidobacteria and lactobacilli 282 
without a significant change of Clostridium and E. coli. Supplementation with Synergy1 also 283 
reduced the concentration of protein metabolites (ammonia with significance and BCFA but 284 
not reaching significance); in those donors with high production of VOCs, inhibition was also 285 
found with Synergy1. An inulin rich diet could be beneficial in individuals with high protein 286 
diet, however, this effective dose of inulin is relatively difficult to achieve, especially in 287 
people consuming a Western diet (51, 52). Therefore, adding fructan prebiotics could 288 
potentially reduce the negative consequences of ingesting high protein diets, although this 289 
would need to be demonstrated in vivo. EFSA have approved the use of chicory inulin at a 290 
dosage of 12g per day to maintain normal bowel function, however, the effective does of 291 
prebiotics to regulate bacterial proteolysis is unknown (53). In this study, 5g of inulin type 292 
fructans were effective in vitro, but production of metabolites such as phenol and indole was 293 
only inhibited in some of the donors. This needs to be validated in vivo and a higher dose 294 
might have a better inhibitory effect and cover more of the population. This study also 295 
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revealed the importance of host habitual diet on the metabolic function of human gut 296 
microbiome. This infers that host diet shapes the gut bacteria in a profound way. The 297 
individual difference is significant which again could due to individual diet difference.  298 
Materials 299 
Proteins 300 
Protein substrates used were casein hydrolysate (Sigma-Aldrich, Poole, UK, meat extract for 301 
microbiology (Sigma-Aldrich, Poole, UK), soy protein acid hydrolysate powder (Sigma-302 
Aldrich, Poole, UK), and mycoprotein which was extracted from a commercial product 303 
(QuornTM) purchased from a local supermarket.  304 
Prebiotic 305 
Inulin-type fructan was a mixture of oligofructose and inulin: 50%±10% DP (degree of 306 
polymerisation) 3-9 and 50%±10% DP≥10 (Orafti®Synergy 1, BENEO-Orafti, Tienen, 307 
Belgium).  308 
Methods 309 
Protein extraction 310 
Mycoproteins were extracted from QuornTM based on the method described by R. J. H. 311 
Williams et al. (54). QuornTM mince (500g) was mixed with 1200ml water and then 312 
homogenised in a blender. 60ml of formic acid was added after homogenisation and the pH 313 
lowered to 1.6. Afterwards, 5g pepsin was added and the solution incubated at 37°C for 48 314 
hours. Samples were centrifuged at 3000g for 15 minutes and the supernatants freeze-dried 315 
for later use. After extraction, the nitrogen content of mycoproteins was quantified using the 316 
Kjeldahl method (Campden BRI, UK) and was found to be 10.3%. The remaining 317 
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mycoprotein was stored at -20°C. 318 
Protein dose determination 319 
Based on previous validation work from in vitro batch culture experiments and in human 320 
trials, the dose of 1% of substrate (w/v) equates to 5g inulin reaching the colon (27, 55). 321 
Synergy1 (1% w/v) was used in this study to investigate the prebiotic effect. The approach 322 
used in a 150ml batch culture experiments to simulate high protein ingestion is shown in 323 
Table 2. The amount of casein, meat extract, mycoprotein and soy protein was adjusted based 324 
on their true protein content which is shown in Table 3.  325 
 326 
In vitro batch culture fermentation 327 
 328 
Faecal Sample Preparation 329 
Ethical approval of collecting faecal samples from healthy volunteers was obtained from 330 
University of Reading University Research Ethics Committee in 2014. Faecal samples were 331 
obtained from three healthy meat eating individuals and three healthy vegetarian volunteers 332 
between the ages of 18 and 60 (vegetarians 34.44±6.03 years old and omnivores 29.33±3.06) 333 
who had not taken antibiotics for at least six months prior to the experiment and had no 334 
history of gastrointestinal disorders. None were taking prebiotic supplements. All volunteers 335 
were following their diet for at least 5 years.  336 
Faecal samples were diluted 1 in 10 (w/v) using 1M, pH7.4, anaerobically prepared 337 
phosphate buffered saline (PBS, Oxoid, Hampshire, UK). This solution was homogenised in 338 
a stomacher (Seward, stomacher 80, Biomaster) for 120 seconds at normal speed. 15mL of 339 
this was then immediately used to inoculate batch culture vessels. 340 
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Batch Culture Basal Nutrient Medium. 341 
 342 
Basal nutrient medium was prepared with chemicals obtained from Sigma-Aldrich, Poole, 343 
UK unless otherwise stated. In one litre: 2g peptone water, 2g yeast extract (Oxoid, 344 
Hampshire, UK), 0.1g NaCl, 0.04g K2HPO4 (BDH, Poole, UK), 0.04g KH2PO4 (BDH), 0.01g 345 
MgSO3.7H2O (Fischer scientific, Loughborough, UK), 0.01g CaCl2.6H2O, 2g NaHCO3 346 
(Fischer), 0.5g L–cystine HCl, 2mL Tween 80, 10µL vitamin K1, 0.05g haemin, 0.05g bile 347 
salts (Oxoid), 4ml resazurin (pH7).  348 
 349 
pH controlled, stirred batch culture fermentation 350 
 351 
Vessels with an operating volume of 300mL were set up. 135mL of basal nutrient medium 352 
was autoclaved (121°C for 15 minutes) and aseptically poured into sterile vessels.  This 353 
system was left overnight with oxygen free nitrogen sparging into the medium at a rate of 354 
15mL/min. After 4 hours of fermentation, nitrogen flow was stopped and gas outlets were 355 
clamped to trap gas. pH meters (Electrolab pH controller, Tewksbury, UK) were connected to 356 
each vessel to regulate pH 6.7 to 6.9 with the aid of 0.5M HCl or NaOH.  357 
 358 
Each vessel was also temperature controlled at 37°C and stirred using a magnetic stirrer. 359 
Prebiotic and relative protein treatment were added to the vessels prior to inoculation with 360 
15mL of faecal inoculum. For each donor, 10 vessels were prepared for 10 treatments: casein, 361 
meat extract, Quorn, soy protein, casein+Synergy1, meat extract+Synergy1, 362 
Quorn+Synergy1, soy protein+Synergy1, Synergy1, and a negative control.  363 
 364 
Samples were removed from the fermenters after 0, 6, 10, 24 and 48 hours incubation.  365 
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Enumeration of faecal microbial populations by flow cytometry fluorescence in situ 366 
hybridisation (FISH) 367 
 368 
A 750µl sample of batch culture fluid was centrifuged at 11337 × g for 5 minutes and the 369 
supernatant discarded. The pellet was then suspended in 375µl filtered 0.1M PBS solution. 370 
Filtered cold (4°C) 4% paraformaldehyde (PFA) (1125µl) was added and samples were stored 371 
at 4°C for 4 hours. These were then washed thoroughly with PBS to remove PFA and re-372 
suspended in a mixture containing 300 µl PBS and 300 µl 99% ethanol. Samples were then 373 
stored at -20°C prior to FISH analysis by flow cytometry. Filtered cold (4°C) 0.1M PBS (500 374 
µl) was mixed with fixed samples (75µl), before centrifuged at 11337 × g for 3 minutes. The 375 
pellets were then resuspended in 100µl of TE-FISH (Tris/HCl 1 M pH 8, EDTA 0.5 M pH 8, 376 
and filtered distilled water with the ratio of 1:1:8) containing lysozyme solution (1 mg/ml of 377 
50,000 U/mg protein). Samples were then incubated in the dark at the room temperature for 378 
10 minutes, and then centrifuged at 11337 × g for 3 minutes. Pellets were washed with 500µl 379 
filtered cold PBS, and then washed with 150µl hybridisation buffer (5 M NaCl, 1 M Tris/HCl 380 
pH 8, formamide, ddH2O, 10% SDS with the ratio of 180:20:300:499:1) and centrifuged at 381 
11337 × g for 3 minutes. Pellets were then resuspended in 1ml of hybridisation buffer. 382 
Aliquots (50µl) with 4µl of different probes (50 ng Pl1) were incubated at 35°C for at least 383 
10 hours. The probes used in this study are listed in Table 7. Non Eub, Eub338-I-II-III are 384 
attached with fluorescence Alexa488 at the 5´ end, and other specific probes are attached with 385 
Alexa647. A set of Non Eub, Eub338-I-II-III are attached with fluorescence Alexa647 at the 386 
5´ end to be the controls. For samples to detect specific groups, 4µl of Eub338-I-II-III were 387 
added together with 4µl specific probes. Hybridisation buffer (150µl) was added to each 388 
aliquot after incubation, followed by 3 minutes centrifugation at 11337 × g. Supernatants 389 
(150µl) were carefully removed before samples were centrifuged at 11337 × g for 3 minutes. 390 
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Remaining supernatant was then removed, and pellets were resuspended in 200µl washing 391 
buffer. Washing buffer was prepared as: 12.8µl of 5M Na Cl, 20µl of 1M Tris/HCl pH 8, 10µl 392 
of 0.5 M EDTA pH 8, and 1µl of 10 % SDS in 956.2µl of filtered cold distilled water. 393 
Samples were then incubated at 37°C for 20 minutes and centrifuged at 11337 × g for 3 394 
minutes. After supernatant removal, pellets were resuspended in different volume of filtered 395 
cold PBS based on flow cytometry load. Bacteria counts were then calculated with the 396 
consideration of flow cytometry reading and PBS dilution. 397 
Short chain fatty acid (SCFA) analysis by gas chromatography 398 
Samples were centrifuged at 11337 × g for 10 minutes to remove all particulate matter. 399 
Supernatants were then filtered through a 0.2 µm polycarbonate syringe filter (VWR, 400 
Farlington, UK). Extraction was done with some modifications of a method from A. J. 401 
Richardson et al. (69). Filtered sample (500µl) was transferred into a labelled 100 mm×16 402 
mm glass tube (International Scientific Supplies Ltd, Bradford, England) with 25 μl of 2-403 
ethylbutyric acid (0.1 M, internal standard) (Sigma, Poole, UK). Concentrated HCl (250µl) 404 
and 1 ml diethyl ether were added to each glass tube and samples vortexed for 1 minute. 405 
Samples were then centrifuged at 2000 × g for 10 minutes. The diethyl ether (upper) layer of 406 
each sample was transferred to a labelled clean glass tube. A second extraction was conducted 407 
by adding another 0.5 ml diethyl ether, followed by vortexing and centrifugation. The diethyl 408 
ether layers were pooled. Pooled ether extract (400µl) and 50 μl N-(tert-butyldimethylsilyl)-409 
N-methyltrifluoroacetamide (MTBSTFA) (Sigma-Aldrich, Poole, UK) were added into a GC 410 
screw-cap vial. Samples were left at room temperature for 72 hours to allow lactic acid in the 411 
samples to completely derivatise. 412 
 413 
An Agilent/HP 6890 Gas Chromatograph (Hewlett Packard, UK) using an HP-5MS 414 
30m×0.25mm column with a 0.25μm coating (Crosslinked (5%-phenyl)-methylpolysiloxane, 415 
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Hewlett Packard, UK) was used for analysis of SCFA. Temperatures of injector and detector 416 
were 275°C, with the column programmed from 63°C for 0 minutes to 190°C at 15°C min-1 417 
and held at 190°C for 3 minutes. Helium was the carrier gas (flow rate 1.7 ml min-1; head 418 
pressure 133 KPa). A split ratio of 100:1 was used.  Quantification of the samples was 419 
obtained through calibration curves of lactic acid and acetic, propionic, butyric, valeric and 420 
branched SCFA (iso-butyric and iso-valeric) in concentrations between 12.5 and 100 mM.  421 
 422 
Volatile organic compounds analysis by GC-MS 423 
Entrapment of volatile compounds 424 
 425 
All fermentation samples were adjusted to a pH of 7.0 ± 0.3 using hydrochloric acid or 426 
sodium chloride prior to volatile entrapment. Each sample (1 g) was placed in a 250mL 427 
conical flask fitted with a Dreschel head. The flask was placed in a water bath maintained at a 428 
temperature of 30°C for 1 hour. The flask was attached to oxygen-free nitrogen (40mL/min) 429 
which swept volatile compounds from the headspace above the sample onto a glass trap (4 430 
mm i.d., 6.35 mm o.d. x 90 mm long), containing 85mg of Tenax TA poly (a porous polymer 431 
absorbent based on 2,6-diphenylene-oxide) (Supelco, Poole, UK). Following volatile 432 
extraction, 1µL of 1, 2 dichlorobenzene in methanol (653ng/µL) was added to each trap as an 433 
internal standard and the trap was then flushed with oxygen free nitrogen to remove moisture 434 
(100mL/min) for 10 minutes.  435 
Gas Chromatography and Mass spectrometry (GC-MS) 436 
 437 
Volatile compounds collected on the Tenax adsorbent were analysed using a Perkin-Elmer 438 
Claris 500 GC-MS, attached to an automated thermal desorber (Turbomatrix ATD, Perkin 439 
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Elmer, Beaconsfield, UK).  Tenax traps were desorbed at 300°C for 10 min and the volatiles 440 
cryofocused on the internal cold trap held at -30°C. After desorption, the cold trap was heated 441 
to 300 °C at 40°C per second to release volatile material onto the GC column. GC separation 442 
was carried out on a DB-5 non-polar column (60m x 0.32mm id, 1µm film thickness, J&W 443 
Scientific from Agilent). Helium at 145 kPa was used as the carrier gas. The GC oven 444 
temperature program was 2min at 40°C followed by an increase at 4°C/min up to 260°C, 445 
where it was held for 10 min.  All data were collected and stored using Turbomax software 446 
(version 3.5, Perkin Elmer). Compounds were identified from their mass spectra and 447 
identities confirmed by comparison of retention time (linear retention index, LRI) and mass 448 
spectra with those of authentic compounds analysed in online library database. Analyses were 449 
carried out using Agilent 6890/5975 GC-MS system (Agilent Technologies, Palo Alto, CA, 450 
USA) fitted with a Turbomatrix ATD.  451 
Indole, p-cresol and phenol (Sigma-Aldrich, Poole, UK) were diluted using the same internal 452 
standard which was 1, 2 dichlorobenzene in methanol (653ng/µL). Quantification of the 453 
samples was obtained through calibration curves of phenol, p-cresol, indole and skatole in 454 
concentrations between 25 and 100 µg/ml. 455 
 456 
Ammonia Analysis 457 
Samples at 0, 10 and 24 hours were diluted 1 in 50 v/v prior to analysis. Ammonia 458 
concentration of diluted fermentation samples was analysed using a FluoroSELECT™ 459 
ammonia kit (Sigma-Aldrich, Poole, UK). Reagent was prepared by combining 100 μL assay 460 
buffer, 4 μL reagent A and 4 μL reagent B in the kit. 10 μL H2O (blank) and 10 μL sample 461 
was added to each glass vial. Afterwards, 100 μL reagent was added to each tube. Samples 462 
were kept in the dark for 15 minutes at room temperature before they were read in the 463 
fluorometer. Ammonia standards were prepared by diluting 20 mmol/L NH4Cl in distilled 464 
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water and the concentration range was 0.25-1 mmol/L).  465 
Statistical analysis 466 
All statistical tests were performed with the use of IBM SPSS Statistics version 24 (IBM 467 
Corp, US). Results are presented as means ± SD. Changes in specific bacterial groups, 468 
organic acids, and ammonia were assessed among different treatments and time points using 469 
two-way ANOVA. Significant differences were assessed by post hoc Tukey HSD test. In 470 
addition, to monitor the influence of protein and prebiotics independent t tests were used for 471 
all variables. For branched chain fatty acid and ammonia, two-way ANOVA was used to 472 
assess treatment effect and donor difference.  473 
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 646 
Figure 1 Bacterial counts as log10 CFU/mL in the single stage batch culture as analysed by FISH. Values are mean values at 24 and 48 hours 647 
fermentation from 3 omnivores’ microbiota ± standard deviation. a: * Mean values were significantly different between control and protein 648 
without Synergy1 (p<0.05). ** Mean values were significantly different between control and protein without Synergy1 (p<0.01). b: # Mean 649 
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values were significantly different between protein with and without Synergy1 (p<0.05). ## Mean values were significantly different between 650 
protein with and without Synergy1 (p<0.01). ### Mean values were significantly different between protein with and without Synergy1 651 
(p<0.001). 652 
 653 
 654 
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Figure 2 Bacterial counts as log10 CFU/mL in the single stage batch culture as analysed by FISH. Values are mean values at 24 and 48 hours 656 
fermentation from 3 vegetarians’ microbiota ± standard deviation. * Mean values were significantly different between control and protein 657 
without Synergy1 (p<0.05). ** Mean values were significantly different between control and protein without Synergy1 (p<0.01). # Mean values 658 
were significantly different between protein with and without Synergy1 (p<0.05). ## Mean values were significantly different between protein 659 
with and without Synergy1 (p<0.01). ### Mean values were significantly different between protein with and without Synergy1 (p<0.001). 660 
 661 
 662 
 663 
 664 
 665 
 666 
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 667 
Figure 3 SCFA differences between sample with and without protein as mM in the single stage batch culture. Values are mean values at 24 and 668 
48 hours fermentation from 3 omnivores’ microbiota and 3 vegetarians’ microbiota ± standard deviation. * Mean values were significantly 669 
different between control and protein without Synergy1 (p<0.05). ** Mean values were significantly different between control and protein 670 
without Synergy1 (p<0.01). *** Mean values were significantly different between control and protein without Synergy1 (p<0.001). # Mean 671 
values were significantly different between protein with and without Synergy1 (p<0.05). ## Mean values were significantly different between 672 
protein with and without Synergy1 (p<0.01). ### Mean values were significantly different between protein with and without Synergy1 673 
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(p<0.001). 674 
 675 
Figure 4 BCFA and valerate differences between sample with and without protein as mM in the single stage batch culture. Values are mean 676 
values at 24 and 48 hours fermentation from 3 omnivores’ microbiota and 3 vegetarians’ microbiota ± standard deviation. * Mean values were 677 
significantly different between control and protein without Synergy1 (p<0.05). ** Mean values were significantly different between control and 678 
protein without Synergy1 (p<0.01). *** Mean values were significantly different between control and protein without Synergy1 (p<0.001). # 679 
Mean values were significantly different between protein with and without Synergy1 (p<0.05). ## Mean values were significantly different 680 
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between protein with and without Synergy1 (p<0.01). ### Mean values were significantly different between protein with and without Synergy1 681 
(p<0.001). 682 
 683 
Figure 5 Lactate and succinate differences between sample with and without protein as mM in the single stage batch culture. Values are mean 684 
values at 24 and 48 hours fermentation unless specified from 3 omnivores’ microbiota and 3 vegetarians’ microbiota ± standard deviation. a: * 685 
Mean values were significantly different between control and protein without Synergy1 (p<0.05). ** Mean values were significantly different 686 
between control and protein without Synergy1 (p<0.01). *** Mean values were significantly different between control and protein without 687 
Synergy1 (p<0.001). b: # Mean values were significantly different between protein with and without Synergy1 (p<0.05). ## Mean values were 688 
significantly different between protein with and without Synergy1 (p<0.01). ### Mean values were significantly different between protein with 689 
and without Synergy1 (p<0.001). 690 
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 691 
 692 
 693 
 694 
Figure 6 Changes in ammonia concentration 695 
(mM) of batch culture sample over time. Values are mean values at three time points from 3 omnivore and 3 vegetarian faecal donor’s ± standard 696 
deviation. * Mean values were significantly different from 0 hour fermentation samples (p<0.05). 697 
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 699 
 700 
 701 
 702 
 703 
 704 
 705 
 706 
 707 
 708 
 709 
 710 
 Omnivores Vegetarians 
 Control Protein without 
Synergy1a 
Protein with 
Synergy1b 
Control Protein without 
Synergy1a 
Protein with 
Synergy1b 
 n=6 n=12 n=12 n=6 n=12 n=12 
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Ammonia 
in mM 
23.07±9.58 165.24±77.44*** 91.16±33.24** 32.02±8.97 153.53±62.69*** 126.64±35.76 
Table 1 Ammonia concentration in samples as mM in the single stage batch culture. Values are mean values at 24 hours fermentation from 3 711 
omnivores’ microbiota and 3 vegetarians’ microbiota ± standard deviation. a: *** Mean values were significantly different between control and 712 
protein without Synergy1 (p<0.001). b: ** Mean values were significantly different between protein with and without Synergy1 (p<0.01).  713 
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 725 
 In vitro fermentation dosage 
Dietary protein 2.4g 
Mucin 0.57g 
Digestive enzymes 0.18g 
Note: digestive enzyme is a mixture of 0.107g pepsin, 0.022g pancreatin, and 0.00079g α-
amylase based on an in vitro upper gut digestion simulation paper (56) 
Table 2 Endogenous and exogenous protein dosage to simulate the in vivo effect of 105g dietary protein per day consumption for 150ml batch 726 
culture experiment.  727 
 728 
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 735 
 736 
 737 
 738 
 739 
 740 
 741 
 742 
 743 
 744 
Protein Protein content Protein dose 
Casein 68.75% 3.5g 
Soy protein 75% 3.2g 
Meat extract 76% 3.2g 
Mycoprotein 64.2% 3.7g 
Table 3 Protein dose that is equivalent to 2.4g dietary protein responding with protein content 745 
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 746 
 747 
Table 4 Name, sequence, and target group of oligonucleotide probes used in this study for FISH of bacterial enumeration  748 
 
Probe 
name 
 
Sequence (5’ to 3’) 
 
Target groups 
 
References 
Non Eub ACTCCTACGGGAGGCAG
C 
Control probe complementary to EUB338  (57) 
Eub338 GCTGCCTCCCGTAGGAG
T 
Most Bacteria (58) 
Eub338II GCAGCCACCCGTAGGTG
T 
Planctomycetales (59) 
Eub338II
I 
GCTGCCACCCGTAGGTG
T 
Verrucomicrobiales (59) 
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Bif164 CATCCGGCATTACCACCC Bifidobacterium spp. (60) 
Lab158 GGTATTAGCAYCTGTTTC
CA 
Lactobacillus and Enterococcus (61) 
Bac303 CCAATGTGGGGGACCTT Most Bacteroidaceae and Prevotellaceae, some 
Porphyromonadaceae 
(62) 
Erec482 GCTTCTTAGTCARGTACC
G 
Most of the Clostridium coccoides-Eubacterium rectale group 
(Clostridium cluster XIVa and XIVb) 
(63) 
Rrec584 TCAGACTTGCCGYACCG
C 
Roseburia genus (64) 
Ato291 GGTCGGTCTCTCAACCC Atopobium cluster (65) 
Prop853 ATTGCGTTAACTCCGGC
AC 
Clostridial cluster IX (64) 
Fprau65 CGCCTACCTCTGCACTAC Feacalibacterium prausnitzii and relatives (66) 
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5 
DSV687 TACGGATTTCACTCCT Desulfovibrio genus (67) 
Chis150 TTATGCGGTATTAATCTY
CCTTT 
Most of the Clostridium histolyticum group (Clostridium cluster I 
and II) 
(63) 
EC 1531 CAC CGT AGT GCC TCG 
TCA TCA 
Escherichia coli BJ4 (68) 
  749 
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